This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Use of topical steroids in atopic eczema in children

Authoring team

  • potency of topical corticosteroids should be tailored to the severity of the child's atopic eczema, which may vary according to body site
    • general principles for treatment with topical eczema are:
      • use mild potency for mild atopic eczema
      • use moderate potency for moderate atopic eczema
      • use potent for severe atopic eczema
      • use mild potency for the face and neck, except for short-term (3-5 days) use of moderate potency for severe flares
      • use moderate or potent preparations for short periods only (7-14 days) for flares in vulnerable sites such as axillae and groin
      • do not use very potent preparations in children without specialist dermatological advice
      • topical corticosteroids should only be used on areas with active atopic eczema (or eczema that has been active within the past 48 hours) (1).

Reference:

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.